JPRN-jRCT2080223587已完成2 期
A Randomized, Double Blind, Placebo-Controlled, Study to Assess the Efficacy, Safety, and Tolerability of RO7239361 in Ambulatory Boys with Duchenne Muscular Dystrophy
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 159
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized Intervention Model: Parallel Assignment Masking: Participant, Care Provider, Investigator, Outcomes Assessor Primary Purpose: Treatment
入排标准
- 年龄范围
- >= 6age old 至 <= 11age old（—）
- 性别
- Male
入选标准
- •Diagnosed with DMD by a blood test
- •Able to walk without assistance
- •Able to walk up 4 stairs in 8 seconds or less
- •Weigh at least 15 kg (33 lbs)
- •Taking corticosteroids for DMD
- •Other protocol defined Inclusion/Exclusion Criteria could apply.
排除标准
- •Any behavior or mental issue that will affect the ability to complete the required study procedures
- •Previously or currently taking medications like androgens or human growth hormone
- •Use of a ventilator during the day
- •Unable to have blood samples collected or receive an injection under the skin
- •Other protocol defined Inclusion/Exclusion Criteria could apply.
研究者
相似试验
进行中（未招募）
1 期
Clinical Trial to Evaluate the Efficacy, Safety, and Tolerability of BMS-986089 in Ambulatory Boys With Duchenne Muscular DystrophyMedDRA version: 20.0 Level: PT Classification code 10013801 Term: Duchenne muscular dystrophy System Organ Class: 10010331 - Congenital, familial and genetic disordersDuchenne Muscular DystrophyEUCTR2016-001654-18-ESBristol-Myers Squibb International Corporation160
进行中（未招募）
1 期
Clinical Trial to Evaluate the Efficacy, Safety, and Tolerability of RO7239361 in Ambulatory Boys With Duchenne Muscular DystrophyDuchenne Muscular DystrophyEUCTR2016-001654-18-NLF. Hoffmann-La Roche Ltd166
进行中（未招募）
1 期
Clinical Trial to Evaluate the Efficacy, Safety, and Tolerability of BMS-986089 in Ambulatory Boys With Duchenne Muscular DystrophyDuchenne Muscular DystrophyEUCTR2016-001654-18-FRBristol-Myers Squibb International Corporation160
已完成
3 期
A Randomized, Double Blind, Placebo-Controlled, Study to Assess the Efficacy, Safety, and Tolerability of RO7239361 in Ambulatory Boys with Duchenne Muscular Dystrophy.Muscular Disorder10028396Duchenne Muscular DystrophyNL-OMON48814Hoffmann-La Roche10
进行中（未招募）
1 期
Clinical Trial to Evaluate the Efficacy, Safety, and Tolerability of RO7239361 in Ambulatory Boys With Duchenne Muscular DystrophyDuchenne Muscular DystrophyEUCTR2016-001654-18-GBF. Hoffmann-La Roche Ltd159